Page last updated: 2024-08-23

promegestone and Cardiovascular Diseases

promegestone has been researched along with Cardiovascular Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Conard, J; Hellgren, M; Kluft, C; Norris, L	1
Kenemans, P; Post, MS; Stehouwer, CD; Teerlink, T; van der Mooren, MJ; Verhoeven, MO	1

Trials

2 trial(s) available for promegestone and Cardiovascular Diseases

Article	Year
Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone. Maturitas, 2009, Mar-20, Volume: 62, Issue:3 Topics: Adult; Aged; Biomarkers; Blood Coagulation Factors; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Fibrinolysis; Humans; Lipids; Middle Aged; Postmenopause; Progestins; Promegestone; Risk Factors; Thromboembolism; Uterine Hemorrhage	2009
Effect of hormone replacement therapy on plasma levels of the cardiovascular risk factor asymmetric dimethylarginine: a randomized, placebo-controlled 12-week study in healthy early postmenopausal women. The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:9 Topics: Arginine; Biomarkers; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Humans; Isomerism; Middle Aged; Progesterone Congeners; Promegestone; Risk Factors; Spectrometry, Fluorescence	2003

Article

Year

Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone.

Maturitas, 2009, Mar-20, Volume: 62, Issue:3

Topics: Adult; Aged; Biomarkers; Blood Coagulation Factors; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Fibrinolysis; Humans; Lipids; Middle Aged; Postmenopause; Progestins; Promegestone; Risk Factors; Thromboembolism; Uterine Hemorrhage

2009

Effect of hormone replacement therapy on plasma levels of the cardiovascular risk factor asymmetric dimethylarginine: a randomized, placebo-controlled 12-week study in healthy early postmenopausal women.

The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:9

Topics: Arginine; Biomarkers; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Humans; Isomerism; Middle Aged; Progesterone Congeners; Promegestone; Risk Factors; Spectrometry, Fluorescence

2003